Hepatic lysosomal acid lipase overexpression worsens hepatic inflammation in mice fed a Western diet

Autor: Gavin Fredrickson, Fanta Barrow, Michael W. Lopresti, Douglas G. Mashek, Arnav S. Desai, Xavier S. Revelo, Breann Abernathy, Wenqi Cui
Rok vydání: 2021
Předmět:
Male
RNA-Seq
RNA sequencing

Biochemistry
chemistry.chemical_compound
Mice
iWAT
inguinal white adipose tissue

Endocrinology
Lipid droplet
lipase/hepatic
Nonalcoholic fatty liver disease
CE
cholesteryl ester

Chemistry
Kupffer cell
LAL
lysosomal acid lipase

TEM
transmission electron microscope

Mo/MF
monocyte-derived macrophage

DE
differentially expressed

medicine.anatomical_structure
dietary fat
Cholesteryl ester
lysosomal acid lipase
Female
medicine.symptom
NK
natural killer

Research Article
medicine.medical_specialty
autophagy
LD
lipid droplet

TAG
triacylglycerol

Inflammation
QD415-436
liver
Immune system
Internal medicine
NAFLD
GO
Gene Ontology

medicine
Animals
KC
Kupffer cell

FPC
fructose
palmitate
and cholesterol

Triglyceride
immune infiltration
nutritional and metabolic diseases
Cell Biology
Sterol Esterase
IPA
ingenuity pathway analysis

medicine.disease
cholesterol/cell and tissue
digestive system diseases
Mice
Inbred C57BL

SFA
saturated FA

Disease Models
Animal

Diet
Western

NAFLD
nonalcoholic fatty liver disease

Steatosis
Zdroj: Journal of Lipid Research
Journal of Lipid Research, Vol 62, Iss, Pp 100133-(2021)
ISSN: 1539-7262
Popis: Nonalcoholic fatty liver disease (NAFLD) is characterized by the accumulation of lipid droplets in hepatocytes. NAFLD development and progression is associated with an increase in hepatic cholesterol levels and decreased autophagy and lipophagy flux. Previous studies have shown that the expression of lysosomal acid lipase (LAL), encoded by the gene LIPA, which can hydrolyze both triglyceride and cholesteryl esters, is inversely correlated with the severity of NAFLD. In addition, ablation of LAL activity results in profound NAFLD. Based on this, we predicted that overexpressing LIPA in the livers of mice fed a Western diet would prevent the development of NAFLD. As expected, mice fed the Western diet exhibited numerous markers of NAFLD, including hepatomegaly, lipid accumulation, and inflammation. Unexpectedly, LAL overexpression did not attenuate steatosis and had only minor effects on neutral lipid composition. However, LAL overexpression exacerbated inflammatory gene expression and infiltration of immune cells in mice fed the Western diet. LAL overexpression also resulted in abnormal phagosome accumulation and lysosomal lipid accumulation depending upon the dietary treatment. Overall, we found that hepatic overexpression of LAL drove immune cell infiltration and inflammation and did not attenuate the development of NAFLD, suggesting that targeting LAL expression may not be a viable route to treat NAFLD in humans.
Databáze: OpenAIRE